Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy

BACKGROUND: Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been associated with excess weight gain. Whether similar gains are seen after switch to INSTIs among virologically suppressed persons is less clear. We assessed pre/post-INSTI weight changes from AIDS Clinical Tr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Infect Dis
Main Authors: Lake, Jordan E, Wu, Kunling, Bares, Sara H, Debroy, Paula, Godfrey, Catherine, Koethe, John R, McComsey, Grace A, Palella, Frank J, Tassiopoulos, Katherine, Erlandson, Kristine M
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Online Only Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7713693/
https://ncbi.nlm.nih.gov/pubmed/32099991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa177
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki